StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.87+0.15 (+4.03%)

Close on Nov 13, 2026Market cap $143.89MP/E –Yield –

Armata Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Armata Pharmaceuticals

Armata Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Armata Pharmaceuticals figures

See a number that looks wrong?